
1. eneurologicalsci. 2016 jan 4;3:17-20. doi: 10.1016/j.ensci.2015.12.001.
ecollection 2016 jun.

does survival motor neuron copy number variation play role onset and
severity sporadic amyotrophic lateral sclerosis malians?

sangare m(1), dicko i(1), guinto co(2), sissoko a(2), dembele k(2), coulibaly
y(1), coulibaly sy(1), landoure g(2), diallo a(1), dolo m(1), dolo h(1), maiga
b(2), traore m(2), karembe m(2), traore k(3), toure a(4), sylla m(4), togora
a(3), coulibaly s(3), traore sf(5), hendrickson b(6), bricceno k(7), schindler
ab(7), kokkinis a(7), meilleur kg(7), sangho ha(8), diakite b(1), kassogue y(1), 
coulibaly yi(1), burnett b(7), maiga y(9), doumbia s(8), fischbeck kh(7).

author information: 
(1)faculty medicine, university sciences techniques technologies of
bamako (usttb), bamako, mali.
(2)neurology department, teaching hospital point g, village point g, bamako,
mali.
(3)psychiatry department, teaching hospital point g, village point g, bamako, 
mali.
(4)pediatry department, teaching hospital gabriel touré, bamako, mali.
(5)malaria research training center, faculty medicine, usttb, bamako,
mali.
(6)labcorp, boston, ma, united states.
(7)neurogenetics branch, national institute neurological disorders stroke,
nih, bethesda, md 20892, united states.
(8)department education research public health, faculty medicine,
usttb, bamako, mali.
(9)neurology department, teaching hospital gabriel touré, bamako, mali.

introduction: spinal muscular atrophy (sma) sporadic amyotrophic lateral
sclerosis (sals) motor neuron disorders. sma results deletion
of survival motor neuron (smn) 1 gene. high low smn1 copy number the
absence smn2 reported risk factors development or
severity sals.
objective: investigate role smn gene copy number onset and
severity sals malians.
material methods: determined smn1 smn2 copy number genomic dna 
samples 391 malian adult volunteers, 120 yoruba nigeria, 120 luyha from
kenya 74 u.s. caucasians using taqman quantitative pcr assay. evaluated 
the sals risk based estimated sma protein level using veldink formula 
(smn1 copy number + 0.2 ∗ smn2 copy number). also characterized disease
natural history 15 als patients teaching hospital point g, bamako,
mali.
results: found 131 391 (33.5%) estimated smn protein expression
of ≤ 2.2; 60 391 (15.3%) estimated smn protein expression < 2 and
would risk als disease onset early 16 years old. all
15 patients male physically handicapped within 1-2 years in
the disease course.
conclusion: short survival time patients, family histories 
and sample dna testing done. however, results show sporadic
als earlier onset shorter survival time compared patients
elsewhere. plan establish network neurologists researchers for
early screening als.

doi: 10.1016/j.ensci.2015.12.001 
pmcid: pmc5803066
pmid: 29430530 

